Charlotte's Web Holdings Inc Stock Canadian Securities Exchange

Equities

CWEB

CA16106R1091

Pharmaceuticals

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Charlotte's Web Holdings Inc -1.63% +27.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 57.55M 78.65M Sales 2025 * 62.95M 86.03M Capitalization 26.47M 36.18M
Net income 2024 * -29M -39.63M Net income 2025 * -16M -21.87M EV / Sales 2024 * 0.46 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.42 x
P/E ratio 2024 *
-0.89 x
P/E ratio 2025 *
-1.68 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.84%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Charlotte's Web Holdings Inc

Managers TitleAgeSince
Chief Executive Officer 60 23-09-12
Founder 37 13-12-02
Director of Finance/CFO 36 22-12-31
Members of the board TitleAgeSince
Chairman 61 18-05-17
Director/Board Member 52 22-12-05
Director/Board Member 63 22-08-09
More insiders
Charlotte's Web Holdings, Inc. (Charlotte’s) is engaged in providing hemp extract wellness products under a family of brands which includes Charlotte’s Web, CBD Medic, CBD Clinic, and Harmony Hemp. Charlotte’s Web branded products start with its hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include full spectrum hemp extract oil tinctures (liquid products), gummies (sleep, calm, immunity, exercise recovery, daily wellness, THC-free), capsules, topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web products are distributed to retail outlets and health care practitioners, as well as online through the Company’s Website at www.Charlottesweb.com.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.1683 USD
Average target price
0.475 USD
Spread / Average Target
+182.15%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW